Gene: EIF4G3
Official Full Name: eukaryotic translation initiation factor 4 gamma 3provided by HGNC
Gene Summary: The protein encoded by this gene is thought to be part of the eIF4F protein complex, which is involved in mRNA cap recognition and transport of mRNAs to the ribosome. Interestingly, a microRNA (miR-520c-3p) has been found that negatively regulates synthesis of the encoded protein, and this leads to a global decrease in protein translation and cell proliferation. Therefore, this protein is a key component of the anti-tumor activity of miR-520c-3p. [provided by RefSeq, May 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33961 | EIF4G3 Knockout cell line (HeLa) | Human | EIF4G3 | 1:3~1:6 | Negative | Online Inquiry |
KO33962 | EIF4G3 Knockout cell line (HCT 116) | Human | EIF4G3 | 1:2~1:4 | Negative | Online Inquiry |
KO33963 | EIF4G3 Knockout cell line (HEK293) | Human | EIF4G3 | 1:3~1:6 | Negative | Online Inquiry |
KO33964 | EIF4G3 Knockout cell line (A549) | Human | EIF4G3 | 1:3~1:4 | Negative | Online Inquiry |
EIF4G3 Gene Knockout Cell Lines are specialized cellular models engineered to lack the EIF4G3 gene, which encodes a crucial component of the eukaryotic translation initiation complex. These cell lines enable researchers to investigate the role of EIF4G3 in cellular processes such as protein synthesis, cellular growth, and response to stress. By completely knocking out this gene, scientists can elucidate its specific contributions to mRNA translation and help identify potential pathways involved in various diseases, particularly in the context of cancer progression and metastasis where translational control is often altered.
The mechanisms at play include the disruption of the interaction between EIF4G3 and other translation factors, ultimately affecting the initiation phase of protein synthesis. By monitoring these changes, researchers can gain insights into how aberrations in translation initiation can lead to disease. The EIF4G3 Knockout Cell Lines are pivotal in advancing our understanding of gene function, validating the roles of potential drug targets, and exploring therapeutic interventions that could rectify dysfunctional translation.
Compared to traditional cell lines that express the gene of interest, our knockout models provide a unique opportunity to negate the gene's effects entirely, offering clearer insights into the consequences of EIF4G3 loss. This specificity enhances the accuracy of experimental results, making these cell lines an essential tool for both basic research and therapeutic development.
The value of EIF4G3 Gene Knockout Cell Lines extends beyond their use in basic research; they are pivotal in high-throughput screening and drug discovery, allowing for the assessment of compound efficacy and mechanism of action in translational research contexts. Researchers and clinicians benefit immensely from these cell lines, as they represent a step forward in the exploration of innovative therapeutic strategies.
Our company prides itself on its expertise in developing cutting-edge biological models that empower scientific discovery. Through rigorous quality control and validation, we ensure that our products meet the highest standards of research integrity and reliability, supporting the advancement of life sciences globally.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.